BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 31998240)

  • 1. Regulatory Role of RNA N
    Chen X; Hua W; Huang X; Chen Y; Zhang J; Li G
    Front Endocrinol (Lausanne); 2019; 10():911. PubMed ID: 31998240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mettl3 Regulates Osteogenic Differentiation and Alternative Splicing of Vegfa in Bone Marrow Mesenchymal Stem Cells.
    Tian C; Huang Y; Li Q; Feng Z; Xu Q
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.
    Shen GS; Zhou HB; Zhang H; Chen B; Liu ZP; Yuan Y; Zhou XZ; Xu YJ
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3644-3654. PubMed ID: 30279140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mettl3-mediated m
    Wu Y; Xie L; Wang M; Xiong Q; Guo Y; Liang Y; Li J; Sheng R; Deng P; Wang Y; Zheng R; Jiang Y; Ye L; Chen Q; Zhou X; Lin S; Yuan Q
    Nat Commun; 2018 Nov; 9(1):4772. PubMed ID: 30429466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of m6A modification in osteogenesis of stem cells.
    Zou Z; He T; Liu Y; Zheng L; Zhong Y; Mo Y; Peng S; Shuai C
    J Bone Miner Metab; 2022 Mar; 40(2):177-188. PubMed ID: 35091784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging.
    Wang Y; Chen Y; Xiao H; Liu Z; Liu X; Feng Z; Sheng X; Peng B; Ren X; Xu L; Teng F; Yi Z; Niu Y; Xiang D; Xia Y; Geng B
    Cell Death Discov; 2024 Mar; 10(1):155. PubMed ID: 38538596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A Methylation Regulates Osteoblastic Differentiation and Bone Remodeling.
    Huang M; Xu S; Liu L; Zhang M; Guo J; Yuan Y; Xu J; Chen X; Zou J
    Front Cell Dev Biol; 2021; 9():783322. PubMed ID: 34993198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPβ pathway
    Yao Y; Bi Z; Wu R; Zhao Y; Liu Y; Liu Q; Wang Y; Wang X
    FASEB J; 2019 Jun; 33(6):7529-7544. PubMed ID: 30865855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Yan G; Yuan Y; He M; Gong R; Lei H; Zhou H; Wang W; Du W; Ma T; Liu S; Xu Z; Gao M; Yu M; Bian Y; Pang P; Li X; Yu S; Yang F; Cai B; Yang L
    Mol Ther Nucleic Acids; 2020 Mar; 19():421-436. PubMed ID: 31896070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Roles of RNA N6-Methyladenosine in Urological Tumors.
    Li Y; Ge YZ; Xu L; Xu Z; Dou Q; Jia R
    Front Cell Dev Biol; 2020; 8():579919. PubMed ID: 33015074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A demethylase FTO and osteoporosis: potential therapeutic interventions.
    Huang M; Guo J; Liu L; Jin H; Chen X; Zou J
    Front Cell Dev Biol; 2023; 11():1275475. PubMed ID: 38020896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-Printed β-Tricalcium Phosphate Scaffolds Promote Osteogenic Differentiation of Bone Marrow-Deprived Mesenchymal Stem Cells in an N6-methyladenosine-Dependent Manner.
    Jiao X; Sun X; Li W; Chu W; Zhang Y; Li Y; Wang Z; Zhou X; Ma J; Xu C; Dai K; Wang J; Gan Y
    Int J Bioprint; 2022; 8(2):544. PubMed ID: 35669331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.
    Yuan Y; Du Y; Wang L; Liu X
    J Cancer; 2020; 11(12):3588-3595. PubMed ID: 32284755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome.
    Shi W; Yang F; Dai R; Sun Y; Chu Y; Liao S; Hao B
    Front Cell Dev Biol; 2021; 9():621374. PubMed ID: 33869171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.
    Xiang S; Liang X; Yin S; Liu J; Xiang Z
    Am J Transl Res; 2020; 12(5):1789-1806. PubMed ID: 32509177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Mettl3 ameliorates osteoblastic senescence by mitigating m6A modifications on Slc1a5 via Igf2bp2-dependent mechanisms.
    Liu XW; Xu HW; Yi YY; Zhang SB; Chang SJ; Pan W; Wang SJ
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(7):167273. PubMed ID: 38844111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-Methyladenosine in Cell-Fate Determination of BMSCs: From Mechanism to Applications.
    Zhang Q; Li J; Wang C; Li Z; Luo P; Gao F; Sun W
    Research (Wash D C); 2024; 7():0340. PubMed ID: 38665846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic m
    Xie SJ; Lei H; Yang B; Diao LT; Liao JY; He JH; Tao S; Hu YX; Hou YR; Sun YJ; Peng YW; Zhang Q; Xiao ZD
    Front Cell Dev Biol; 2021; 9():744171. PubMed ID: 34660602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.